Long-circulating polymeric nanovectors for tumor-selective gene delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Gene therapy holds promise for neoplastic diseases, with viral vectors dominating current protocols.
• Viral vectors pose risks including insertional mutagenesis and replication-competent virus formation.
• Polymeric nanoparticles are emerging as a safer non-viral gene delivery alternative.

Purpose of the Study:

• To review the application of hydrophilic polymers in enhancing nanocarrier circulation time for gene delivery.
• To analyze the mechanisms and factors influencing nanocarrier circulation.
• To explore strategies for improving target specificity and address limitations of steric stabilization.

Main Methods:

• Review of literature on hydrophilic polymer coatings for nanocarriers.
• Analysis of nanoparticle-cell interactions, particularly uptake by the reticuloendothelial system (RES).
• Discussion of polyethylene glycol (PEG)ylation and its impact on pharmacokinetics.

Main Results:

• Hydrophilic polymer coatings, such as PEG, reduce RES uptake, prolonging nanocarrier circulation time.
• Improved circulation time enhances the potential for nanocarriers to reach target sites.
• Steric stabilization by polymers can be modified to improve target specificity.

Conclusions:

• Hydrophilic polymer-coated nanocarriers represent a significant advancement in non-viral gene delivery.
• Optimizing polymer coatings is crucial for overcoming limitations like poor transfection efficiency and RES clearance.
• Further research into targeted delivery strategies will enhance the therapeutic potential of nanocarrier-based gene therapy.